Clinical Trial: Artemether/Lumefantrine and Vivax Malaria

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Artemether/Lumefantrine in the Treatment of Plasmodium Vivax Malaria in Eastern Sudan

Brief Summary: The cure rate of artemether/lumefantrine in the treatment of vivax malaria.

Detailed Summary:
Sponsor: University of Khartoum

Current Primary Outcome: The cure rate [ Time Frame: 28 days ]

The proportion of the cure patients


Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Fever clearance time [ Time Frame: 28 days ]
    The time for fever clearance
  • Parasite clearance time [ Time Frame: 28 days ]
    The time for the parasite to clear


Original Secondary Outcome: Same as current

Information By: University of Khartoum

Dates:
Date Received: June 17, 2012
Date Started: September 2011
Date Completion:
Last Updated: January 16, 2013
Last Verified: January 2013